Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc. (TPST) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TPST · as of Jun 9, 2026
Key Statistics
Explore Tempest Therapeutics, Inc. Data
tpst stock data · financialsCompetitors & Peers
tpst competitorsTPST
ALGS
ATNM
BRNS
FGEN
INMBAbout Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc. Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer. The firm's pipeline highligh…
what is tempest therapeutics, inc. · tpst stock overview · tempest therapeutics, inc. company profile · who is tempest therapeutics, inc. ceo · tpst NASDAQ · tempest therapeutics, inc. headquarters · tempest therapeutics, inc. business segments
About Stock Overview & Key Data
Tempest Therapeutics, Inc. (TPST) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 12, 2012. As of the latest trading session, TPST stock price is $1.27, with a market capitalization of $5.6M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Tempest Therapeutics, Inc. (TPST) stock price is $1.27. The stock is traded on NASDAQ under the ticker symbol TPST. The 52-week range is $1.23 – $12.23.